Eric Weinberg - Rxsight CoPresident Officer
| RXST Stock | USD 46.38 1.55 3.46% |
President
Eric Weinberg is CoPresident Officer of Rxsight
| Age | 63 |
| Address | 100 Columbia, Aliso Viejo, CA, United States, 92656 |
| Phone | 949 521 7830 |
| Web | https://www.rxsight.com |
Eric Weinberg Latest Insider Activity
Tracking and analyzing the buying and selling activities of Eric Weinberg against Rxsight stock is an integral part of due diligence when investing in Rxsight. Eric Weinberg insider activity provides valuable insight into whether Rxsight is net buyers or sellers over its current business cycle. Note, Rxsight insiders must abide by specific rules, including filing SEC forms every time they buy or sell Rxsight'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Eric Weinberg over three months ago Disposition of 10000 shares by Eric Weinberg of Rxsight at 48.0006 subject to Rule 16b-3 | ||
Eric Weinberg over three months ago Acquisition by Eric Weinberg of 92200 shares of Rxsight at 56.07 subject to Rule 16b-3 | ||
Eric Weinberg over six months ago Sale by Eric Weinberg of 10000 shares of Rxsight |
Rxsight Management Efficiency
The company has return on total asset (ROA) of (0.0992) % which means that it has lost $0.0992 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1399) %, meaning that it created substantial loss on money invested by shareholders. Rxsight's management efficiency ratios could be used to measure how well Rxsight manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to -0.25 in 2024. Return On Capital Employed is likely to drop to -0.33 in 2024. Change To Liabilities is likely to gain to about 6.6 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 15.2 M in 2024.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Brian Giambattista | Varex Imaging Corp | 65 | |
| Gregory Odle | Orthopediatrics Corp | 54 | |
| Kimberley Honeysett | Varex Imaging Corp | 54 | |
| David Bailey | Orthopediatrics Corp | 45 | |
| Carlton Reckling | Si Bone | 62 | |
| Tyler Lipschultz | Orthofix Medical | 57 | |
| Daniel Gerritzen | Orthopediatrics Corp | 54 | |
| Joseph Hauser | Orthopediatrics Corp | 41 | |
| Erick DeVinney | Axogen Inc | 48 | |
| Scott Yerby | Si Bone | 56 | |
| Aviva McPherron | Orthofix Medical | N/A | |
| Moshe Citronowicz | Apyx Medical | 71 | |
| Todd Hornsby | Apyx Medical | 47 | |
| Jon Serbousek | Orthofix Medical | 63 | |
| Angelo Scopelianos | Axogen Inc | 68 | |
| Kimberley Elting | Orthofix Medical | 59 | |
| Kevin Kenny | Orthofix Medical | 59 | |
| Mark Jonaitis | Varex Imaging Corp | 62 | |
| MBAMSHA CHE | Orthopediatrics Corp | 52 | |
Management Performance
| Return On Equity | -0.14 | ||||
| Return On Asset | -0.0992 |
Rxsight Leadership Team
Elected by the shareholders, the Rxsight's board of directors comprises two types of representatives: Rxsight inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Rxsight. The board's role is to monitor Rxsight's management team and ensure that shareholders' interests are well served. Rxsight's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Rxsight's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Matt Haller, Chief Officer | ||
| Alex Huang, Investor Relations | ||
| Oliver Moravcevic, Vice Relations | ||
| Ilya Goldshleger, CoPresident Officer | ||
| Scott Gaines, Senior Process | ||
| Ronald MD, CEO President | ||
| Caroline Vaughn, Vice Resources | ||
| Steve Everly, Senior America | ||
| Rebecca Williston, Vice Finance | ||
| Eric Weinberg, CoPresident Officer | ||
| Roy Freeman, Senior Relations | ||
| Maureen OConnell, Senior Affairs | ||
| Shelley Thunen, CoPresident Officer |
Rxsight Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Rxsight a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.14 | ||||
| Return On Asset | -0.0992 | ||||
| Profit Margin | (0.24) % | ||||
| Operating Margin | (0.26) % | ||||
| Current Valuation | 1.64 B | ||||
| Shares Outstanding | 40.3 M | ||||
| Shares Owned By Insiders | 5.09 % | ||||
| Shares Owned By Institutions | 89.52 % | ||||
| Number Of Shares Shorted | 2.74 M | ||||
| Price To Earning | 42.55 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Rxsight Stock Analysis
When running Rxsight's price analysis, check to measure Rxsight's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rxsight is operating at the current time. Most of Rxsight's value examination focuses on studying past and present price action to predict the probability of Rxsight's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rxsight's price. Additionally, you may evaluate how the addition of Rxsight to your portfolios can decrease your overall portfolio volatility.